CN108277243B - 一种假单胞菌酸a的制备方法 - Google Patents
一种假单胞菌酸a的制备方法 Download PDFInfo
- Publication number
- CN108277243B CN108277243B CN201810054033.2A CN201810054033A CN108277243B CN 108277243 B CN108277243 B CN 108277243B CN 201810054033 A CN201810054033 A CN 201810054033A CN 108277243 B CN108277243 B CN 108277243B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- acid
- concentration
- pseudomonic acid
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title claims abstract description 59
- MINDHVHHQZYEEK-HBBNESRFSA-N mupirocin Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-HBBNESRFSA-N 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000000855 fermentation Methods 0.000 claims abstract description 93
- 230000004151 fermentation Effects 0.000 claims abstract description 93
- 239000007788 liquid Substances 0.000 claims abstract description 44
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 28
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 28
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 28
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 28
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 241000589540 Pseudomonas fluorescens Species 0.000 claims abstract description 25
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 16
- 239000001509 sodium citrate Substances 0.000 claims abstract description 15
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 15
- 239000001963 growth medium Substances 0.000 claims abstract description 14
- 230000001502 supplementing effect Effects 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000001888 Peptone Substances 0.000 claims description 7
- 108010080698 Peptones Proteins 0.000 claims description 7
- 235000019319 peptone Nutrition 0.000 claims description 7
- 238000011218 seed culture Methods 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 238000005273 aeration Methods 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- 238000009423 ventilation Methods 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 13
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- JGKQAKOVZJHZTF-LHSFDMIQSA-N 9-[(e)-3-methyl-4-[(2s,3r,4s,5r)-3,4,5-trihydroxy-5-[[(2s,3s)-3-[(2s,3s)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@]1(O)[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)OC1 JGKQAKOVZJHZTF-LHSFDMIQSA-N 0.000 description 4
- JGKQAKOVZJHZTF-LMLZBOKOSA-N Pseudomonic acid B Natural products O=C(OCCCCCCCCC(=O)O)/C=C(\C[C@H]1[C@H](O)[C@H](O)[C@@](O)(C[C@H]2[C@@H]([C@H]([C@@H](O)C)C)O2)CO1)/C JGKQAKOVZJHZTF-LMLZBOKOSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- RJGJFSVDQPCELW-VCXQKUNESA-N (e)-9-[(e)-4-[(2s,3r,4r,5s)-3,4-dihydroxy-5-[[(2s,3s)-3-[(2s,3s)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynon-4-enoic acid Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCC\C=C\CCC(O)=O)OC1 RJGJFSVDQPCELW-VCXQKUNESA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- RJGJFSVDQPCELW-IZCYIFJBSA-N Pseudomonic D Natural products O=C(OCCCC/C=C/CCC(=O)O)/C=C(\C[C@H]1[C@H](O)[C@H](O)[C@@H](C[C@H]2[C@@H]([C@H]([C@@H](O)C)C)O2)CO1)/C RJGJFSVDQPCELW-IZCYIFJBSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- RJGJFSVDQPCELW-UHFFFAOYSA-N pseudomonic acid D Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCC=CCCC(O)=O)OC1 RJGJFSVDQPCELW-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KKMHFUKZHJOMJL-ZDACLCLWSA-N (+)-Pseudomonic acid C Natural products O=C(OCCCCCCCCC(=O)O)/C=C(\C[C@H]1[C@@H](O)[C@H](O)[C@H](C/C=C/[C@H]([C@@H](O)C)C)CO1)/C KKMHFUKZHJOMJL-ZDACLCLWSA-N 0.000 description 2
- KKMHFUKZHJOMJL-WZLBZGCNSA-N 9-[(e)-4-[(2s,3r,4r,5s)-3,4-dihydroxy-5-[(e,4r,5s)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid Chemical compound C[C@H](O)[C@H](C)\C=C\C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O KKMHFUKZHJOMJL-WZLBZGCNSA-N 0.000 description 2
- KKMHFUKZHJOMJL-UHFFFAOYSA-N Pseudomonic acid C Natural products CC(O)C(C)C=CCC1COC(CC(C)=CC(=O)OCCCCCCCCC(O)=O)C(O)C1O KKMHFUKZHJOMJL-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- UGUYQBMBIJFNRM-OQFOIZHKSA-N [(z)-but-2-en-2-yl]benzene Chemical group C\C=C(\C)C1=CC=CC=C1 UGUYQBMBIJFNRM-OQFOIZHKSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N noncarboxylic acid Natural products CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810054033.2A CN108277243B (zh) | 2018-01-19 | 2018-01-19 | 一种假单胞菌酸a的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810054033.2A CN108277243B (zh) | 2018-01-19 | 2018-01-19 | 一种假单胞菌酸a的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108277243A CN108277243A (zh) | 2018-07-13 |
CN108277243B true CN108277243B (zh) | 2021-03-12 |
Family
ID=62804171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810054033.2A Active CN108277243B (zh) | 2018-01-19 | 2018-01-19 | 一种假单胞菌酸a的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108277243B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108949845B (zh) * | 2018-08-08 | 2021-08-10 | 福建康鸿生物科技有限公司 | 一种发酵培养基及由发酵培养基制备莫匹罗星的方法 |
US20240043888A1 (en) * | 2021-02-07 | 2024-02-08 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Fermentation method for mupirocin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354798A (zh) * | 1999-02-03 | 2002-06-19 | 拜奥盖尔药厂有限公司 | 经微生物学方法制备假单胞菌酸a抗生素的方法 |
CN103820369A (zh) * | 2014-03-07 | 2014-05-28 | 浙江瑞邦药业有限公司 | 一种萤光假单胞菌及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002345856A1 (en) * | 2001-06-21 | 2003-01-08 | Biogal Gyogyszergyar Rt | Metabolic controlled fermentation process for pseudomonic acid production |
-
2018
- 2018-01-19 CN CN201810054033.2A patent/CN108277243B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354798A (zh) * | 1999-02-03 | 2002-06-19 | 拜奥盖尔药厂有限公司 | 经微生物学方法制备假单胞菌酸a抗生素的方法 |
CN103820369A (zh) * | 2014-03-07 | 2014-05-28 | 浙江瑞邦药业有限公司 | 一种萤光假单胞菌及其应用 |
Non-Patent Citations (2)
Title |
---|
Biosynthesis of mupirocin by pseudomonas fluorescens NCIMB 10586 involves parallel pathways;Shu-shan GAO;《Journal of American chemical society》;20141231;第136卷(第14期);第5501-5507页 * |
莫匹罗星的菌种选育与发酵工艺的研究;杨正行;《中国优秀硕士学位论文全文数据库工程科技I辑》;20130215;第2013卷;第B030-I页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108277243A (zh) | 2018-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110551786B (zh) | 一种提高a40926 b0产量的发酵培养基及其方法 | |
CN101245362B (zh) | 发酵法生产多肽类抗生素安来霉素的方法 | |
CN112359002B (zh) | 一株小白链霉菌及其在生产ε-聚赖氨酸中的应用 | |
CN109082448B (zh) | 一种大肠杆菌及其在发酵生产1,5-戊二胺中的应用 | |
CN109593807B (zh) | 一种发酵生产安普霉素的方法 | |
CN108277243B (zh) | 一种假单胞菌酸a的制备方法 | |
CN113293110B (zh) | 一种抗菌脂肽类化合物的制备方法 | |
CN110656065B (zh) | 一株生产ε-聚赖氨酸的链霉菌及其应用 | |
CN102220396A (zh) | 阿卡波糖简易的发酵方法 | |
CN102154419A (zh) | 一种用于提高恩拉霉素产量的发酵培养基 | |
CN111172050B (zh) | 一株伯克霍尔德氏菌高产毒黄素的发酵策略 | |
CN109207536B (zh) | 一种提高米尔贝霉素发酵产物中米尔贝霉素a3含量的方法 | |
Elisashvili et al. | Extracellular polysaccharide production by culinary-medicinal Shiitake mushroom Lentinus edodes (Berk.) Singer and Pleurotus (Fr.) P. Karst. species depending on carbon and nitrogen source | |
CN106591401B (zh) | 一种用于提高庆大霉素C1a产量的发酵促进剂及添加方法 | |
CN115181774A (zh) | 一种提高多粘菌素b有效组分含量的发酵液制备方法 | |
CN113046257B (zh) | 一种短小芽孢杆菌的发酵培养方法 | |
CN113396214B (zh) | 从链霉菌属sp.mcc 0151生产尼日利亚菌素的方法 | |
CN107164438B (zh) | 一种提高短短芽孢杆菌细菌素生产水平的发酵方法 | |
CN114621886A (zh) | 一种枯草芽孢杆菌发酵产抗菌肽工艺及制备方法 | |
CN113337417A (zh) | 一种高效降解氨基甲酸乙酯的农杆菌及其应用 | |
CN112813122A (zh) | 一种Aureobasidin A的发酵制备方法及其培养基 | |
CN106319005B (zh) | 一种可提高那西肽产量的发酵培养基及培养方法 | |
CN113234766B (zh) | 一种添加微生物诱导子的ε-聚赖氨酸生物合成方法 | |
CN114606276B (zh) | 提高l-苏氨酸发酵产量的方法 | |
CN116606780B (zh) | 一株假黄单胞菌属细菌njau-t129及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Preparation Method of Pseudomonas Acid A Effective date of registration: 20231221 Granted publication date: 20210312 Pledgee: Zhejiang Juzhou Commercial Bank Co.,Ltd. Wenzhou Ouhai Branch Pledgor: ZHEJIANG RUIBANG MEDICINE CO.,LTD. Registration number: Y2023980072527 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210312 Pledgee: Zhejiang Juzhou Commercial Bank Co.,Ltd. Wenzhou Ouhai Branch Pledgor: ZHEJIANG RUIBANG MEDICINE CO.,LTD. Registration number: Y2023980072527 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |